Jove
Visualize
Contact Us

Related Experiment Videos

Massive hemobilia.

Kuan-Long Hsu1, Sheung-Fat Ko, Fong-Fu Chou

  • 1Department of Surgery, Chang Gung Memorial Hospital, Kaohsiung Medical Center, Kaohsiung, Hsien, Taiwan. h605@ms16.hinet.net

Hepato-Gastroenterology
|May 9, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

2025 Update of the Taiwan Expert Consensus on Hormone Receptor-Positive Metastatic Breast Cancer Management.

Journal of breast cancer·2026
Same author

Effect of Preoperative Transarterial Embolization on Surgical Blood Loss in Thyroidectomy for Large Graves' Disease.

World journal of surgery·2026
Same author

Combined Empagliflozin and Sacubitril/Valsartan Therapy Additively Improves Cardiorenal Function Through AMPK Activation and Angiotensin II Type 1 Receptor Signaling Attenuation in a Rat Model of Cardiorenal Syndrome.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026
Same author

Alirocumab therapy effectively suppresses colorectal cancer cell growth and invasion in nude mouse liver - PCSK9 is a key driver of PI3K/Akt/p-Bad-mediated cell proliferation and antiapoptotic signaling.

International journal of surgery (London, England)·2025
Same author

Double gene overexpression of ZNF746 and cellular prion protein in rat adipose-derived mesenchymal stromal cell therapy protects the liver against ischemia‒reperfusion injury.

Cell transplantation·2025
Same author

Nanog overexpression enhances the therapeutic efficacy of ADMSCs in AMI rats via the upregulation of JAK/STAT3 signaling and cyclin-mitochondrial expression.

International journal of biological sciences·2025
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Massive hemobilia, often caused by biliary drainage procedures, can be life-threatening. Many cases are successfully managed with blood transfusions, while other interventions offer alternative treatments for upper gastrointestinal hemorrhage.

Area of Science:

  • Gastroenterology
  • Interventional Radiology
  • Surgical Oncology

Background:

  • Massive hemobilia presents as a rare but critical cause of upper gastrointestinal bleeding.
  • This study reviews 15 cases of massive hemobilia with diverse etiologies and treatment approaches.

Purpose of the Study:

  • To analyze the causes, clinical presentations, and treatment outcomes of massive hemobilia.
  • To evaluate the efficacy of various management strategies for this condition.

Main Methods:

  • Retrospective review of 15 patients diagnosed with massive hemobilia over 8.5 years.
  • Massive hemobilia defined by biliary bleeding requiring at least 4 units of whole blood transfusion.

Main Results:

  • Percutaneous transhepatic biliary drainage was the most frequent cause (7/15 patients).

Related Experiment Videos

  • Blood transfusion alone was successful in 8 patients; other treatments included transarterial embolization and hepatic artery ligation.
  • Mortality occurred in 4 patients, with malignancy being a factor in two cases.

    • Conclusions:

    • Percutaneous transhepatic biliary drainage is a primary cause of massive hemobilia.
    • While blood transfusion is often sufficient, interventional radiology and surgical procedures are effective alternatives.
    • Careful management of the main hepatic artery is crucial during biliary drainage procedures.